Recombinant Human CD183

Este producto es parte de CXCR - C-X-C motif chemokine receptor
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Recombinant Human CD183
category
Proteins and Peptides
provider
FineTest
reference
P2362
tested applications
Western Blot, ELISA

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

CategoryProteins and Peptides
Immunogen Target3-53
HostE.Coli
OriginHuman
Observed MW26.3 kDa
ExpressionRecombinant
PurityGreater than 70% by SDS-PAGE gel analyses
PurificationIF2DI tag
Size 150μg
Size 2200μg
Size 31mg
FormLyophilized from a 0.2um filtered solution in PBS with 5% trehalose, pH7.4
Tested ApplicationsWestern Blot, ELISA
BufferReconstitute with Sterile distilled water
Availability7 days
Storage-20°C for 12 months as lyophilized;2-8°C for 1 month under sterile conditions after reconstitution
UniProt IDP49682
AliasCXCR3,GPR9,MigR,CD182,CD183,Mig-R,CKR-L2,CMKAR3,IP10-R,G protein-coupled receptor 9,CXC-R3,interferon-inducible protein 10 receptor,IP-10 receptor
BackgroundProteins CXCR3
StatusRUO
NoteThis product is for research use only.

CXCR3 is a G protein-coupled receptor (GPCR) primarily expressed on activated T cells, natural killer (NK) cells, and some epithelial cells. It binds chemokines such as CXCL9, CXCL10, and CXCL11, which are induced by interferon-gamma during inflammation. CXCR3 plays a critical role in T cell trafficking, promoting migration to inflammatory sites and tumor microenvironments. Its activation triggers signaling pathways like PI3K, MAPK, and JAK/STAT, leading to cell migration, proliferation, and cytokine production. CXCR3 has two main isoforms, CXCR3-A and CXCR3-B, which mediate different functions: CXCR3-A drives chemotaxis and immune cell recruitment, while CXCR3-B can induce apoptosis and inhibit cell migration under specific conditions. CXCR3 is implicated in autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease, where aberrant T cell migration leads to chronic inflammation. In cancer, CXCR3 regulates both pro- and anti-tumor responses; while it facilitates immune cell infiltration into tumors, it can also enhance tumor cell metastasis and angiogenesis in some cancers. Its expression in tumor cells has been linked to poor prognosis, particularly in melanoma, breast, and lung cancers. Pharmacological targeting of CXCR3 is being explored to modulate immune responses, reduce inflammation, and improve cancer immunotherapy. Overall, CXCR3 is essential for immune cell migration, balancing immune surveillance and disease progression.

Related Products

EH0982

Human CXCR3(C-X-C chemokine receptor type 3) ELISA Kit

Ver Producto
EM0968

Mouse CXCR3(CXC-chemokine receptor 3) ELISA Kit

Ver Producto
ER0883

Rat CXCR3(CXC-Chemokine Receptor 3) ELISA Kit

Ver Producto
Recombinant Human CD183 | P2362